1887

Abstract

In 1986 we published a review article entitled ‘Some highlights of animal virus research in 1985’, in which we attempted to summarize important and interesting research on animal viruses published in 1985 (McGeoch ., 1986). The limitations of the exercise were recognized: coverage was selective rather than systematic and, outside clearly pre-eminent subjects, was overtly influenced by personal scientific interests. In this article we now present a similar account of animal virology in 1986. Much the same ground rules have been retained. Selectivity remains of the first importance, and our treatment concerns work published in 1986 as far as possible, but with a little flexibility where necessary.

As with 1985, animal virology in 1986 was dominated by work on acquired immune deficiency syndrome (AIDS) retroviruses. Outside this area, however, we were not able to identify any small set of truly outstanding advances, although work in many virus systems clearly made excellent progress. This evaluation posed problems for a review of the type undertaken, in particular for achieving a balanced selection of topics. With this background we also found it more necessary than before to address virus groups in separate sections (representing a step back from the previous, integrative stance). We have chosen to present aspects of research on, first, the AIDS viruses, and then in succession on hepatitis viruses, herpesviruses, poxviruses, papovaviruses, picomaviruses and negative strand viruses, and to finish with a section on virion structure.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-6-1501
1987-06-01
2024-05-02
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/6/JV0680061501.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-6-1501&mimeType=html&fmt=ahah

References

  1. Adachi A., Gendelman H. E., Koening S., Folks T., Willey R., Rabson A., Martin M. A. 1986; Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. Journal of Virology 59:284–291
    [Google Scholar]
  2. Alizon M., Wain-Hobson S., Montagnier L., Sonigo P. 1986; Genetic variability of the AIDS virus. Nucleotide sequence analysis of two isolates from African patients. Cell 46:63–74
    [Google Scholar]
  3. Allan J. S., Coligan J. E., Lee T. H., Mclane M. F., Kanki P. J., Groopman J. E., Essex M. 1985; A new HTLVIII/LAV encoded antigen detected by antibodies from AIDS patients. Science 230:810–813
    [Google Scholar]
  4. Andrews N. C., Baltimore D. 1986a; Purification of a terminal uridylyl transferase that acts as host factor in the in vitro poliovirus replicase reaction. Proceedings of the National Academy of Sciences U.S.A.: 83:221–225
    [Google Scholar]
  5. Andrews N. C., Baltimore D. 1986b; Lack of evidence for VPg priming of poliovirus RNA synthesis in the host factor-dependent in vitro replicase reaction. Journal of Virology 58:212–215
    [Google Scholar]
  6. Andrews N. C., Levin D., Baltimore D. 1985; Poliovirus replicase stimulation by terminal uridylyl transferase. Journal of Biological Chemistry 260:7628–7635
    [Google Scholar]
  7. Beard P., Faber S., Wilcox K. W., Pizer L. I. 1986; Herpes simplex virus immediate early infected-cell polypeptide 4 binds to DNA and promotes transcription. Proceedings of the National Academy of Sciences U.S.A.: 834016–4020
    [Google Scholar]
  8. Berg J. m. 1986; Potential metal-binding domains in nucleic acid binding proteins. Science 232:485–487
    [Google Scholar]
  9. Berg L., Lusky M., Stenlund A., Botchan M. R. 1986; Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor. Cell 46:753–762
    [Google Scholar]
  10. Bernstein H. D., Sonenberg N., Baltimore D. 1985; Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Molecular and Cellular Biology 5:2913–2923
    [Google Scholar]
  11. Blancou J., Kieny M. P., Lathe R., Lecocq J. P., Pastoret P. P., Soulebot J. P., Desettre P. 1986; Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature; London: 322373–375
    [Google Scholar]
  12. Bodemer W., Niller H. h., Nitsche N., Scholz B., Fleckenstein B. 1986; Organization of the thymidylate synthase gene of herpesvirus saimiri. Journal of Virology 60:114–123
    [Google Scholar]
  13. Bodescot M., Perricaudet M. 1986; Epstein-Barr virus mRNAs produced by alternative splicing. Nucleic Acids Research 14:7103–7114
    [Google Scholar]
  14. Bodescot M., Brison O., Perricaudet M. 1986; An Epstein-Barr virus transcription unit is at least 84 kilobases long. Nucleic Acids Research 14:2611–2620
    [Google Scholar]
  15. Bolognesi D. P., Langlois A. J., Matthews T. J., Fischinger F. J., Gallo R. C. 1986; Prospects for development of a vaccine against human lymphotropic virus type III disease. In New Approaches to Immunization, pp 311–321 Brown F., Chanock R. M., Lerner R. A. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  16. Bonino F., Heermann K. H., Rizzetto M., Gerlich W. H. 1986; Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. Journal of Virology 58:945–950
    [Google Scholar]
  17. Brinster R. L., Chen H. Y., Messing A., Dyke T. V., Levine A. J., Palmiter R. D. 1984; Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37:367–379
    [Google Scholar]
  18. Brown F. 1986; Human immunodeficiency virus. Science 232:1486
    [Google Scholar]
  19. Brown F., Schild G. C., Ada G. L. 1986; Recombinant vaccinia viruses as vaccines. Nature; London: 319549–550
    [Google Scholar]
  20. Brown S. E., Stanley C., Howard C. R., Zuckerman A. J., Steward M. W. 1986; Antibody responses to recombinant and plasma derived hepatitis B vaccines. British Medical Journal 292:159–161
    [Google Scholar]
  21. Broyles S., Moss B. 1986; Homology between RNA polymerases of poxviruses, prokaryotes, and eukaryotes: nucleotide sequence and transcriptional analysis of vaccinia virus genes encoding 147-kDa and 22-kDa subunits. Proceedings of the National Academy of Sciences U.S.A.: 833141–3145
    [Google Scholar]
  22. Chakrabarti S., Robert-Guroff M., Wong-Staal F., Gallo R. C., Moss B. 1986; Expression of the HTLV-I1I envelope gene by a recombinant vaccinia virus. Nature; London: 320535–540
    [Google Scholar]
  23. Chen L. S. Y. 1986; Regulation of AIDS virus expression. Cell 47:1–2
    [Google Scholar]
  24. Chen P. J., Kalpana G., Goldberg J., Mason W., Werner B., Gervin J., Taylor J. 1986; Structure and replication of the genome of hepatitis virus. Proceedings of the National Academy of Sciences U.S.A.: 838774–8778
    [Google Scholar]
  25. Clavel F., Klatzmann D., Montagnier L. 1985; Deficient LAV1 neutralizing capacity of sera from patients with AIDS or related syndromes. Lancet i:879–880
    [Google Scholar]
  26. Clavel F., Guetard D., Brun-Vezinet F., Chamaret S., Rey M. A., Santos-Ferreira M. O., Laurent A. G., Danguet C., Katlama C., Rouzioux C., Klatzmann D., Champalimud J. L., Montagnier L. 1986; Isolation of a new human retrovirus from West African patients with AIDS. Science 233:343–346
    [Google Scholar]
  27. Coffin J., Haase A., Levy J. A., Montagnier L., Oroszlan S., Teich N., Temin H., Toyoshima K., Varmus H. E., Vogt P. K., Weiss R. A. 1986; What to call the AIDS virus. Nature; London: 32110
    [Google Scholar]
  28. Cohen E. A., Gaudreau P., Brazeau P., Langelier Y. 1986; Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature; London: 321441–443
    [Google Scholar]
  29. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C., Smith G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
    [Google Scholar]
  30. Cullen B. R. 1986; Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46:973–982
    [Google Scholar]
  31. Davidson M., Krugman S. 1986; Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine : immunogenicity and effect of a booster dose. Journal of Infection 13: Supplement A 31–38
    [Google Scholar]
  32. Davison A. J., Mcgeoch D. J. 1986; Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. Journal of General Virology 67:597–611
    [Google Scholar]
  33. Davison A. J., Scott J. E. 1986; The complete DNA sequence of varicella-zoster virus. Journal of General Virology 67:1759–1816
    [Google Scholar]
  34. Davison A. J., Waters D. J., Edson C. M. 1985; Identification of the products of a varicella-zoster virus glycoprotein gene. Journal of General Virology 66:2237–2242
    [Google Scholar]
  35. Davison A. J., Edson C. M., Ellis R. W., Forghani B, Grose C., Keller P. M., Vafai A., Wroblewska Z., Yamanlshl K. 1986; New common nomenclature for glycoprotein genes of varicella- zoster virus and their glycosylated products. Journal of Virology 57:1195–1197
    [Google Scholar]
  36. Dayton A. I., Sodroski J. G., Rosen C. A., Goh W. C., Haseltine W. A. 1986; The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44:941–947
    [Google Scholar]
  37. Denniston K. J., Hoyer B. H., Smedile A., Wells V., Nelson J., Gerin J. L. 1986; Cloned fragment of the hepatitis delta virus RNA genome: sequence and diagnostic application. Science 232:873–875
    [Google Scholar]
  38. Dillner J., Kallin B., Alexander H., Ernberg I., Uno M., Uno Y., Klein G., Lerner R. A. 1986; An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation- associated BomWYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Proceedings of the National Academy of Sciences U.S.A.: 836641–6645
    [Google Scholar]
  39. Dutia B. M., Frame M. C., Subak-sharpe J. H., Clark W. N., Marsden H. s. 1986; Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature; London: 321439–441
    [Google Scholar]
  40. Earl P. L., Jones E. V., Moss B. 1986a; Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene. Proceedings of the National Academy of Sciences U.S.A.: 833659–3663
    [Google Scholar]
  41. Earl P. L., Moss B., Morrison R. P., Wehrly K., Nishio J., Chesebro B. 1986b; T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science 234:728–731
    [Google Scholar]
  42. Elango N., Prince G. A., Murphy B. R., Venkatesan S., Chanock R. M., Moss B. 1986; Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences U.S.A.: 83:1906–1910
    [Google Scholar]
  43. Ellis R. W., Keller P. m., Lowe R. s., Zivin R. A. 1985; Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC. Journal of Virology 53:81–88
    [Google Scholar]
  44. Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V. 1985; Increased neurovirulence associated with a single nucleotide change in a non-coding region of the Sabin type 3 poliovaccine genome. Nature; London: 314548–550
    [Google Scholar]
  45. Faber S. W., Wilcox K. W. 1986; Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA. Nucleic Acids Research 14:6067–6083
    [Google Scholar]
  46. Fathi Z., Sridhar P., Pacha R. F., Condit R. C. 1986; Efficient targeted insertion of an unselected marker into the vaccinia virus genome. Virology 155:97–105
    [Google Scholar]
  47. Feinberg M. b., Jarrett R. F., Aldovini A., Gallo R. C., Wong-staal F. 1986; HTLV-1II expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807–817
    [Google Scholar]
  48. Feitelson M. A., Millman I., Blumberg B. S. 1986a; Tree squirrel hepatitis virus: antigenic and structural characterization. Proceedings of the National Academy of Sciences U.S.A.: 832994–2997
    [Google Scholar]
  49. Feitelson M. A., Millman I., Halbherr T., Simmons H., Blumberg B. s. 1986b; A newly identified hepatitis B virus in tree squirrels. Proceedings of the National Academy of Sciences U.S.A.: 832233–2237
    [Google Scholar]
  50. Fisher A. G., Collati B., Ratner L., Gallo R. C., Wong-Staal F. 1985; A molecular clone of HTLV-III with biological activity. Nature; London: 316262–265
    [Google Scholar]
  51. Fisher A. G., Feinberg M. B., Josephs S. F., Harper M. E., Marselle L. M., Reyes G., Gonda M. A., Aldovini A., Debouk C., Gallo R. C., Wong-Staal F. 1986; The trans-activator gene of HTLVIII is essential for virus replication. Nature; London: 320367–371
    [Google Scholar]
  52. Folks T., Powell D. M., Lightfoote M. M., Benn S., Martin M. A., Fanci A. S. 1986; Induction of HTLVIII/LAV from a non-virus-producing T-cell line: implications for latency. Science 231:600–602
    [Google Scholar]
  53. Fuerst T. R., Niles E. G., Studier F. W., Moss B. 1986; Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proceedings of the National Academy of Sciences U.S.A.: 838122–8126
    [Google Scholar]
  54. Fultz P. N., Mcclure H. M., Swenson R. B., Mcgrath C. R., Brodie A., Gechell J. P., Jensen F. C., Anderson D. C., Broderson J. R., Francis D. P. 1986; Persistent infection of chimpanzees with human T- lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodefi-ciency syndrome. Journal of Virology 58:116–124
    [Google Scholar]
  55. Gallo R. C., Reitz M., Streicher H. Z. 1986; Human T-lymphotropic virus type III (HTLVIII/LAV). Approaches to the development of a vaccine for a human retrovirus. In New Approaches to Immunization pp 327–334 Brown F., Chanock R. M., Lerner R. A. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  56. Goedert J. J., Bigger R. J., Weiss S. H., Eyster M. E., Melby M., Wilson S., Ginzburg H. M., Grossman R. J., Digioia R. A., Sanchez W. C., Giron J. A., Erbesen P., Gallo R. C., Blattner W. A. 1986; Three-year incidence of AIDS in five cohorts of HTLVIII-infected risk group members. Science 231:992–995
    [Google Scholar]
  57. Goh W. C., Rosen C., Sodroski J., Ho D. o., Haseltine W. A. 1986; Identification of a protein encoded by the transactivator gene tatlll of human T cell lymphotropic retrovirus type III. Journal of Virology 59:181–184
    [Google Scholar]
  58. Hahn B. H., Shaw G. M., Taylor M. E., Redfield R. R., Markham P. D., Salahuddin S. Z., Wong-Staal F., Gallo R. C., Parks E. S., Parks W. P. 1986; Genetic variation in HTLVIII/LAV over time in patients with AIDS or at risk for AIDS. Science 232:1548–1553
    [Google Scholar]
  59. Hanahan D. 1985; Heritable formation of pancreatic /1-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature; London: 315115–122
    [Google Scholar]
  60. Harper M. E., Marselle L. m., Gallo R. C., Wong-staal F. 1986; Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proceedings of the National Academy of Sciences U.S.A.: 83772–776
    [Google Scholar]
  61. Heermann K. H., Goldmann U., Schwartz W., Seyffarth T., Baumgarten H., Gerlich W. H. 1984; Large surface proteins of hepatitis B virus containing the pre-s sequence. Journal of Virology 52:396–402
    [Google Scholar]
  62. Hellstrom U., Sylvan S., Kuhns S., Sarvin V. 1986; Absence of pre-S2 antibodies in natural hepatitis B virus infection. Lancet ii:889–893
    [Google Scholar]
  63. Hey T. D., Richards O. C., Ehrenfeld E. 1986; Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro. Journal of Virology 58:790–796
    [Google Scholar]
  64. Hirt P., Hiller G., Wittek R. 1986; Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. Journal of Virology 58:757–764
    [Google Scholar]
  65. Honess R. W., Bodemer W., Cameron K. R., Niller H.-H., Fleckenstein B., Randall R. E. 1986; The A + T- rich genome of herpesvirus saimiri contains a highly conserved gene for thymidylate synthase. Proceedings of the National Academy of Sciences U.S.A.: 833604–3608
    [Google Scholar]
  66. Howard C. R. 1986; The biology of hepadnaviruses. Journal of General Virology 67:1215–1235
    [Google Scholar]
  67. Hu S.-L., Kosowski S. g., Dalrymple J. M. 1986; Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature; London: 320537–540
    [Google Scholar]
  68. Josephs S. F., Salahuddin S. Z., Ablashi D. V., Schachter F., Wong-Staal F., Gallo R. C. 1986; Genomic analysis of the human B-lymphotropic virus (HBLV). Science 234:601–603
    [Google Scholar]
  69. Kallin B., Dillner J., Ernberg I., Ehlin-Henriksson B., Rosen A., Henle W., Henle G., Klein G. 1986; Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proceedings of the National Academy of Sciences U.S.A.: 831499–1503
    [Google Scholar]
  70. Kan N. C., Frachini G., Wong-Staal F., Dubois G. C., Robey W. G., Lautenberger J. A., Papas T. S. 1986; Identification of HTLV-III/LAV sor gene products and detection of antibodies in human sera. Science 231:1553–1555
    [Google Scholar]
  71. Kanki P. J., Barin F., M’Boup S., Allan J. S., Romet-Lemonne J. L., Marlink R., Mclane M. F., Lee T. H., Arbeille B., Denis F., Essex M. 1986; New human T-lymphotropic retrovirus related to simian T- lymphotropic virus type III (STLV-III AGM). Science 232:238–243
    [Google Scholar]
  72. Keller P. M., Davison A. J., Lowe R. S., Bennett C. D., Ellis R. W. 1986; Identification and structure of the gene coding gpll, a major glycoprotein of varicella-zoster virus. Virology 152:181–191
    [Google Scholar]
  73. Kennedy R. C., Henkel R. D., Pauletti D., Allan J. S., Lee T. H., Essex M., Dreesman G. R. 1986; Antiserum to a synthetic peptide recognizes the HTLVIII envelope glycoprotein. Science 231:1556–1559
    [Google Scholar]
  74. Kinloch R. A., Mackay N., Mautner V. 1984; Adenovirus hexon: sequence comparison of subgroup C serotypes 2 and 5. Journal of Biological Chemistry 259:6431–6436
    [Google Scholar]
  75. Kos A., Dijkema R., Arnberg A. C., Van Der Meide P. H., Schellekens H. 1986; The hepatitis delta (6) virus possesses a circular RNA. Nature; London: 323:558–560
    [Google Scholar]
  76. Kristie T. M., Roizman B. 1986; DNA-binding site of major regulatory protein a4 specifically associated with promoter-regulatory domains of a genes of herpes simplex virus type 1. Proceedings of the National Academy of Sciences U.S.A.: 834700–4704
    [Google Scholar]
  77. Kurath G., Ahren K. g., Pearson G. D., Leong J. C. 1985; Molecular cloning of the six mRNA species of infectious hematopoietic necrosis virus, a fish rhabdovirus, and gene order determination by R-loop mapping. Journal of Virology 53:469–476
    [Google Scholar]
  78. Lacey M., Alpert S., Hanahan D. 1986; Bovine papillomavirus genome elicits skin tumours in transgenic mice. Nature; London: 322609–612
    [Google Scholar]
  79. Lasky L. A., Groopman J. E., Fennie C. W., Benz P. M., Capon D. J., Dowbenco D. J., Nakamura G. R., Nunes W. M., Renz M. E., Berman O. W. 1986; Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science 233:209–212
    [Google Scholar]
  80. Lee K. A. W., Edery I., Hanecak R., Wimmer E., Sonenberg N. 1985; Poliovirus protease 3C (P3-7c) does not cleave P220 of the eucaryotic mRNA cap-binding protein complex. Journal of Virology 55:489–493
    [Google Scholar]
  81. Lee T. H., Coligan J. E., Allan J. S., Mclane M. F., Groopman I. E., Essex M. 1986; A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science 231:1546–1549
    [Google Scholar]
  82. Levy J. A., Cheng-Mayer C., Dina D., Luciw P. A. 1986; AIDS-retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science 232:998–1001
    [Google Scholar]
  83. Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L., Banapour B., Chakrabarti S., Moss B., Wong-Staal F., Steimer K. S., Engleman E. G. 1986a; Induction of CD4-dependent cell fusion by the HTLVIII/LAV envelope glycoprotein. Nature; London: 323725–728
    [Google Scholar]
  84. Lifson J. D., Reyes G. R., Mcgrath M. S., Stein B. S., Engleman E. G. 1986b; AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 232:1123–1127
    [Google Scholar]
  85. Lloyd R. E., Etchison D., Ehrenfeld E. 1985; Poliovirus protease does not mediate cleavage of the 220000-Da component of the cap binding protein complex. Proceedings of the National Academy of Sciences U.S.A.: 822723–2727
    [Google Scholar]
  86. Lloyd R. E., Toyoda H., Etchison D., Wimmer E., Ehrenfeld E. 1986; Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology 150:299–303
    [Google Scholar]
  87. Lubinski J. M., Kaplan G., Racaniello V. R., Dasgupta A. 1986; Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase. Journal of Virology 58:459–467
    [Google Scholar]
  88. Mcdougal J. S., Kennedy M. S., Sligh J. M., Cost S. P., Marvle A., Nicholson J. K. A. 1986; Binding of HTLVIII/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382–385
    [Google Scholar]
  89. Mcgeoch D. J., Davison A. J. 1986; Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Research 14:1765–1777
    [Google Scholar]
  90. Mcgeoch D. J., Dolan A., Donald S., Brauer H. K. 1986a; Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Research 14:1727–1745
    [Google Scholar]
  91. Mcgeoch D. J., Halliburton I. W., Ter Meulen V., Pringle C. R. 1986b; Some highlights of animal virus research in 1985. Journal of General Virology 67:813–830
    [Google Scholar]
  92. Maddon P. J., Dalgleish A. G., Mcdougal J. S., Clapham P., Weiss R. A., Axel R. 1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348
    [Google Scholar]
  93. Mann I. H., Bila K., Colebunders R. L., Kalemba K., Khonde N., Bosenge N., Nzilambi N., Malonga M., Jansengers L., Francis H., Mccormick J. B., Piot P., Quinn T. C., Curran J. W. 1986a; Natural history of human immunodeficiency virus infection in Zaire. Lxincet ii:707–709
    [Google Scholar]
  94. Mann J. H., Francis H., Davachi F., Bavdoux P., Quinn T. C., Nzilambi N., Bosenge N., Colebunders R. L., Piot P., Kabote N., Asila P. K., Malonga M., Curran I. W. 1986b; Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire. Lancet ii:654–657
    [Google Scholar]
  95. Matthews T. J., Langlos A. J., Robey W. G., Chang N. T., Gallo R. C., Fischinger P. J., Bolognesi D. P. 1986; Restricted neutralization of divergent human TTymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proceedings of the National Academy of Sciences U.S.A.: 839709–9713
    [Google Scholar]
  96. Meyers M. L., Trepo L. V., Nath N., Sninsky J. J. 1986; Hepatitis B virus polypeptide X: expression in Escherichia coli and identification of specific antibodies in sera from hepatitis B virus-infected humans. Journal of Virology 57:101–109
    [Google Scholar]
  97. Miller J., Mclachlan A. D., Klug A. 1985; Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO Journal 4:1609–1614
    [Google Scholar]
  98. Minor P. D., John A., Ferguson M., Icenogle J. P. 1986; Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. Journal of General Virology 67:693–706
    [Google Scholar]
  99. Miyanohara A., Imamura T., Araki M., Sugawara K., Ohtomo N., Matsubara K. 1986; Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons. Journal of Virology 59:176–180
    [Google Scholar]
  100. Morein B., Sundquist B., Hoglund S., Dalsgaard K., Osterhaus S. 1984; ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature; London: 308457–460
    [Google Scholar]
  101. Morgan E. M., Rakestraw K. M. 1986; Sequence of the Sendai virus L gene: open reading frames upstream of the main coding region suggest that the gene may be polycistronic. Virology 154:31–40
    [Google Scholar]
  102. Moriarty A. M., Alexander H., Lerner R. A., Thornton G. B. 1985; Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 227:429–433
    [Google Scholar]
  103. Morrison D. K., Moyer R. W. 1986; Detection of a subunit of cellular pol II within highly purified preparations of RNA polymerase isolated from rabbit poxvirus virions. Cell 44:587–596
    [Google Scholar]
  104. Morrow C. D., Gibbons G. F., Dasgupta A. 1985; The host protein required for in vitro replication of poliovirus is a protein kinase that phosphorylates eukaryotic initiation factor-2. Cell 40:913–921
    [Google Scholar]
  105. Neurath A. R., Kent S. B. H., Strick N. 1984; Location and chemical synthesis of a preS gene coded immunodominant epitope of hepatitis B virus. Science 224:392–395
    [Google Scholar]
  106. Neurath A. R., Kent S. B. H., Parker K., Prince A. M., Strick N., Brotman B., Sproul P. 1986a; Antibodies to a synthetic peptide from the pre-S 120-145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4:35–37
    [Google Scholar]
  107. Neurath A. R., Kent S. B. H., Strick N., Parker K. 1986b; Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429–436
    [Google Scholar]
  108. Niles E. G., Condit R. C., Caro O., Davidson K., Matuskick L., Seto J. 1986; Nucleotide sequence and genetic map of the 16-kb vaccinia virus Hin&lU D fragment. Virology 153:96–112
    [Google Scholar]
  109. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. 1986; Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences U.S.A.: 837462–7466
    [Google Scholar]
  110. Osterhaus A., Weijer K., Uytdehaag F., Jarrett O., Sundquist B., Morein B. 1985; Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOM. Journal of Immunology 135:591–596
    [Google Scholar]
  111. Ou J.-H., Laub O., Rutter W. J. 1986; Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proceedings of the National Academy of Sciences U.S.A.: 831578–1582
    [Google Scholar]
  112. Perry L. J., Rixon F. J., Everett R. D., Frame M. C., McGeoch D. J. 1986; Characterization of the IE110 gene of herpes simplex virus type 1. Journal of General Virology 67:2365–2380
    [Google Scholar]
  113. Persing D. H., Varmus H. E., Ganem D. 1986; Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 234:1388–1391
    [Google Scholar]
  114. Pert C. B., Hill J. M., Ruff M. R., Berman R. M., Robey W. G., Arthur L. O., Ruscetti F. W., Ferrar W. L. 1986; Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proceedings of the National Academy of Sciences U.S.A.: 839254–9258
    [Google Scholar]
  115. Pfaff E., Klinkert M.-Q., Theilmann L., Schaller H. 1986; Characterization of large surface proteins of hepatitis B virus by antibodies to preS-S encoded amino acids. Virology 148:15–22
    [Google Scholar]
  116. Pickup D. J., Ink B. S., Hu W., Ray C. A., Joklik W. K. 1986; Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proceedings of the National Academy of Sciences U.S.A.: 837698–7702
    [Google Scholar]
  117. Pizer L. I., Tedder D. G., Betz J. L., Wilcox K. W., Beard P. 1986; Regulation of transcription in vitro from herpes simplex virus genes. Journal of Virology 60:950–959
    [Google Scholar]
  118. Purves F. C., Katan M., Stevely W. S., Leader D. P. 1986; Characteristics of the induction of a new protein kinase in cells infected with herpesviruses. Journal of General Virology 67:1049–1057
    [Google Scholar]
  119. Quinn T. C., Mann J. H., Curran J. W., Piot P. 1986; AIDS in Africa: an epidemiological paradigm. Science 234:955–961
    [Google Scholar]
  120. Racaniello V. R., Meriam C. 1986; Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5′-non-coding region of the viral RNA. Virology 155:498–507
    [Google Scholar]
  121. Rayment I., Baker T. S., Caspar D. L. D., Murakami W. t. 1982; Polyoma virus capsid structure at 22-5A resolution. Nature; London: 295110–115
    [Google Scholar]
  122. Reiher W. E.III Blalock J. E., Brunck T. K. 1986; Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proceedings of the National Academy of Sciences U.S.A.: 839188–9192
    [Google Scholar]
  123. Roberts J. M., Weintraub H. 1986; Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids. Cell 46:741–752
    [Google Scholar]
  124. Roberts M. M., White J. L., Grütter M. G., Burnett R. M. 1986; Three-dimensional structure of the adenovirus major coat protein hexon. Science 232:1148–1151
    [Google Scholar]
  125. Robertson B. H., Grubman M. J., Weddell G. N., Moore D. M., Welsh J. D., Fischer T., Dowbenko D. J., Yansura D. G., Small B., Kleid D. G. 1985; Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. Journal of Virology 54:651–660
    [Google Scholar]
  126. Rodriguez J. F., Kahn J. S., Esteban M. 1986; Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene. Proceedings of the National Academy of Sciences U.S.A.: 839566–9570
    [Google Scholar]
  127. Rosen C. A., Sodroski J. G., Goh W. C., Dayton A. I., Lippke J., Haseltine W. A. 1986; Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. Nature; London: 319555–559
    [Google Scholar]
  128. Rossmann M. G., Arnold E., Erickson J. W., Frankenberger E. A., Griffith J. P., Hecht H.-J., Johnson J. E., Kamer G., Luo M., Mosser A. G., Rueckert R. R., Sherry B., Vriend G. 1985; Structure of a human common cold virus and functional relationship to other picomaviruses. Nature; London: 317145–153
    [Google Scholar]
  129. Rupprecht C. E., Wiktor T. J., Johnston D. H., Hamir A. N., Dietzschold B., Wunner W. H., Glickman L. T., Koprowski H. 1986; Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proceedings of the National Academy of Sciences U.S.A.: 837947–7950
    [Google Scholar]
  130. Salahuddin S. Z., Ablashi D. V., Markham P, Josephs S. F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Staal F., Kramarsky B., Gallo R. C. 1986; Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:569–601
    [Google Scholar]
  131. Salunke D. M., Caspar D. L. D., Garcea R. L. 1986; , Self-assembly of purified polyomavirus capsid protein VP,. Cell 46:895–904
    [Google Scholar]
  132. Sample J., Hummel M., Braun D., Birkenbach M., Kieff E. 1986; Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proceedings of the National Academy of Sciences U.S.A.: 835096–5100
    [Google Scholar]
  133. Sarnow P., Bernstein H. D., Baltimore D. 1986; A poliovirus temperature-sensitive RNA synthesis mutant located in a non-coding region of the genome. Proceedings of the National Academy of Sciences U.S.A.: 83571–575
    [Google Scholar]
  134. Seigel L. J., Ratner L., Josephs S. F., Derse D., Feinberg M. B., Reyes G. R., O’Brien S. J., Wong-Staal F. 1986; Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. Virology 148:226–231
    [Google Scholar]
  135. Semler B. L., Johnson V. H., Tracy S. 1986; A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. Proceedings of the National Academy of Sciences U.S.A.: 831777–1781
    [Google Scholar]
  136. Shida H. 1986; Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150:451–462
    [Google Scholar]
  137. Shioda T., Iwasaki K., Shibuta H. 1986; Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Research 4:1545–1563
    [Google Scholar]
  138. Small J. A., Khoury G., Jay G., Howley P, Scangos G. A. 1986a; , Early regions of JC virus and BK virus induce distinct and tissue-specific tumours in transgenic mice. Proceedings of the National Academy of Sciences U.S.A.: 838288–8292
    [Google Scholar]
  139. Small J. A., Scangos G. A., Cork L., Jay G., Khoury G. 1986b; The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell 46:13–18
    [Google Scholar]
  140. Smith T. J., Kremer M. J., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M. G., Mckinlay M. A., Diana G. D., Otto M. J. 1986; The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286–1293
    [Google Scholar]
  141. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. 1986a; Role of HTLVIII/LAV envelope in syncytium formation and cytopathicity. Nature; London: 322470–474
    [Google Scholar]
  142. Sodroski J., Goh W. C., Rosen C., Dayton A., Terwilliger E., Haseltine W. 1986b; A second post-transcriptional tram-activator gene required for HTLV-III replication. Nature; London: 321412–417
    [Google Scholar]
  143. Sodroski J., Goh W. C., Rosen L., Tartar A., Portetelle D., Burny A., Haseltine W. 1986c; Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science 231:1549–1553
    [Google Scholar]
  144. Stahl H., Dröge P., Knippers R. 1986; DNA helicase activity of SV40 large tumor antigen. EMBO Journal 5:1939–1944
    [Google Scholar]
  145. Starcich B. R., Hahn B. H., Shaw G. M., Mcneely P. D., Modrow S., Wolf H., Parks E. S., Parks W. P., Josephs S.F, Wong-Staal F. 1986; Identification and characterization of conserved and variable regions in the envelope gene of HTLVIII/LAV, the retrovirus of AIDS. Cell 45:637–648
    [Google Scholar]
  146. Stewart M., Vigers G. 1986; Electron microscopy of frozen-hydrated biological material. Nature; London: 319631–636
    [Google Scholar]
  147. Stow N. D., Stlow E. C. 1986; Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmwl 10. Journal of General Virology 67:2571–2585
    [Google Scholar]
  148. Strebel K., Beck E. 1986; A second protease of foot-and-mouth disease virus. Journal of Virology 58:893–899
    [Google Scholar]
  149. Sureau C., Romet-Lemonne J.-L., Mullins J. I., Essex M. 1986; Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47:37–47
    [Google Scholar]
  150. Tartaglia J., Paoletti E. 1985; Physical mapping and DNA sequence analysis of the rifampicin resistance locus in vaccinia virus. Virology 147:394–404
    [Google Scholar]
  151. Tordo N., Poch O., Ermine A., Keith G. 1986a; Primary structure of leader RNA and nucleoprotein genes of the rabies genome: segmented homology with VSV. Nucleic Acids Research 14:2671–2683
    [Google Scholar]
  152. Tordo N., Poch O., Ermine A., Keith G., Rougeon F. 1968b; Walking along the rabies genome: is the large G-L intergenic region a remnant gene?. Proceedings of the National Academy of Sciences U.S.A.: 833914–3918
    [Google Scholar]
  153. Toyoda H., Kohara M., Kataoka Y., Suganuma T., Omata T., Imura N., Nomoto A. 1984; The Complete nucleotide sequence of all three poliovirus serotype genomes: implication for genetic relationship, gene function and antigenic determinants. Journal of Molecular Biology 174:561–585
    [Google Scholar]
  154. Toyoda H., Nicklin M. J.H., Murray M. G., Anderson C. W., Dunn J. J., Studier F. W., Wimmer E. 1986; A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761–770
    [Google Scholar]
  155. Tuttleman J. S., Pugh J. C., Summers J. W. 1986; In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. Journal of Virology 58:17–25
    [Google Scholar]
  156. Uy A., Bruss V., Gerlich W. H., Kochel H. G., Thomssen R. 1986; Precore sequence of hepatitis B virus including e antigen and membrane association of the viral core protein. Virology 155:89–96
    [Google Scholar]
  157. Vogel R. H., Provencher S. W., Von Bonsdorff C.-H., Adrian M., Dubochet J. 1986; Envelope structure of Semliki Forest virus reconstructed from cryo-electron micrographs. Nature; London: 320533–535
    [Google Scholar]
  158. Wands J. R., Fujita Y, Isselbacher K. J., Degott C., Schellekens H., Dazza M.-C., Thiers V., Tiollais P., Brechot C. 1986; Identification and transmission of hepatitis B virus related variants. Proceedings of the National Academy of Sciences U.S.A.: 836608–6612
    [Google Scholar]
  159. Wang K.-S., Choo Q.-L., Weiner A. J., Ou J.-H., Najarian R. C., Thayer R. M., Mullenbach G. T., Denniston K. J., Gerin J. L., Houghton M. 1986; Structure, sequence and expression of the hepatitis delta 0) viral genome. Nature; London: 323508–514
    [Google Scholar]
  160. Weber J. N., Wadsworth J., Rogers L. A., Moshtael O., Scott K., Mcmanus T., Berrie E., Jeffries D. J., Harris J. R. W., Pinching A. J. 1986; Three-year prospective study of HTLVIII/LAV infection in homosexual men. Lancet i:1179–1182
    [Google Scholar]
  161. Weigent D. A., Hoeprich P. D., Bost K. L., Brunck T. K, Reiher W. E.III Blalock W. E. 1986; The HTLV- III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochemical and Biophysical Research Communications 139:367–374
    [Google Scholar]
  162. Weinrich S. L., Hruby D. E. 1986; A tandemly-orientated late gene cluster within the vaccinia virus genome. Nucleic Acids Research 14:3003–3016
    [Google Scholar]
  163. Weiss R. A., Clapham P. R., Cheingsong-Popov R., Dalgleish A. G., Carne C. A., Weller I. V. D., Tedder R. S. 1985; Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature; London: 31669–72
    [Google Scholar]
  164. Weiss R. A., Clapham P. R., Weber J. N., Dalgleish A. G., Lasky L. A., Berman P. W. 1986; Variable and conserved neutralization antigens of human immunodeficiency virus. Nature; London: 324572–575
    [Google Scholar]
  165. Weston K., Barrell B. G. 1986; Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus. Journal of Molecular Biology 192:177–208
    [Google Scholar]
  166. Will H., Salfeld J., Pfaff E., Manso C., Theilmann L., Schaler H. 1986; Putative reverse transcriptase intermediates of human hepatitis B virus in primary liver carcinomas. Science 231:594–596
    [Google Scholar]
  167. Wilton S., Dales S. 1986; Influence of RNA polymerase II upon vaccinia virus-related translation examined by means of α-amanitin. Virus Research 5:323–341
    [Google Scholar]
  168. Wong D. T., Nath N., Sninsky J. J. 1985; Identification of hepatitis B virus polypeptides encoded by the entire pre-J open reading frame. Journal of Virology 55:223–231
    [Google Scholar]
  169. Yarchoan R., Klecker R. W., Weinhold K. J., Marham P. D., Lyerly H. K., Durack D. T., Gelmann E., Nusinoff-Lehrman S., Blum R. M., Barry D. W., Shearer G. M., Fischl M. A., Mitsuya H., Gallo R. C., Collins J. M., Bolognesi D. P., Meyers C. E., Broder S. 1986; Administration of 3′-azido-3′- deoxythymidine, an inhibitor of HTLVIII/LAV replication, to patients with AIDS or AIDS-related complex. Lancet i:575–580
    [Google Scholar]
  170. Young D. C., Tuschall D. M., Flanegan J. B. 1985; Poliovirus RNA-dependent RNA polymerase and host cell protein synthesize product RNA twice the size of poliovirion RNA in vitro. Journal of Virology 54:256–264
    [Google Scholar]
  171. Young D. C., Dunn B. M., Tobin G. J., Flanegan J. B. 1986; Anti-VPg antibody precipitation of product RNA synthesized in vitro by the poliovirus polymerase and host factor is mediated by VPg on the poliovirion RNA template. Journal of Virology 58:715–723
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-6-1501
Loading
/content/journal/jgv/10.1099/0022-1317-68-6-1501
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error